Author

Gary K.L. Chan

Primary ORCID profile (0000-0002-8450-7831 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Gary K.L. ChaniD1 paper · University of California, San Francisco

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Aaron DiaziD· 1 shared Abhilash BarpandaiD· 1 shared Aidan Du· 1 shared Akane YamamichiiD· 1 shared Arun P. WiitaiD· 1 shared Atsuro SaijoiD· 1 shared Chibo Hong· 1 shared Christopher A. Klebanoff· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aaron DiazORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 19, 2023

Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens

Darwin W. Kwok, Nicholas O. Stevers, Takahide Nejo…·Hideho Okada

The paper identifies tumor-wide splicing aberrations that generate public neoantigens, enabling T-cell-based immunotherapies targeting intratumoral heterogeneity.

DOI 10.1101/2023.10.19.563178

humanbulk RNA-seq

𝕏 PostBluesky